Table 1 |
||||
|
Demographic data on patients and healthy controls |
||||
| AAV (N = 86) |
MPO-ANCA (N = 42) |
PR3-ANCA (N = 44) |
HC (N = 69) |
|
|
|
||||
| Age (years)* |
62.2 ± 13.5 |
65.9 ± 10.9 |
59.7 ± 15.2 |
40.4 ± 9.8 |
| Male gender (%) |
69 |
64 |
73 |
59 |
|
|
||||
|
AAV, ANCA-associated vasculitis; MPO-ANCA, antineutrophil cytoplasmic antibodies against myeloperoxidase; PR3-ANCA, ANCA against proteinase 3; HC, healthy controls * Mean ± standard deviation |
||||
|
Slot et al. Journal of Autoimmune Diseases 2006 3:4 doi:10.1186/1740-2557-3-4 |
||||
